1.Therapeutic Plasma Exchange in Pediatric Kidney Disease: 23-year Experience at the Severance Children's Hospital in Korea.
Sun Mi HER ; Keum Hwa LEE ; Ji Hong KIM ; Jae Seung LEE ; Pyung Kil KIM ; Jae Il SHIN
Childhood Kidney Diseases 2017;21(2):81-88
PURPOSE: The American Society for Apheresis provides clinical guidelines for therapeutic apheresis in adults, but there are no guidelines for children. This study aimed to analyze the effect of therapeutic plasma exchange (TPE) in pediatric patients with various kidney diseases in Korea. METHODS: We retrospectively reviewed the data of 16 children (up to 18 years of age) who were admitted to Severance Children's Hospital with refractory kidney disease. All patients received TPE between 1994 and 2016. Clinical and laboratory characteristics such as age, weight, sex, change in blood urea nitrogen (BUN), and creatinine level before and after TPE, and complications after TPE were analyzed. RESULTS: The mean age and weight of the 16 patients at the time of TPE was 11.3±4.0 years and 34.6±17.5 kg, respectively. The BUN level was 35.4 mg/dL before TPE and significantly decreased to 21.5 mg/dL (P=0.025) at 1 week and 20.5 mg/dL (P=0.01) at 1 month after TPE. The creatinine level significantly decreased from 1.20 mg/dL before TPE to 0.90 mg/dL (P=0.02) at 1 week after TPE. Four complications (hypovolemia, anemia, hypocalcemia, and thrombocytopenia) were reported, but were not fatal. CONCLUSION: Our findings suggest that TPE is an effective therapeutic modality in children with refractory kidney disease and can be indicated for the treatment of various kidney diseases.
Adult
;
Anemia
;
Blood Component Removal
;
Blood Urea Nitrogen
;
Child
;
Creatinine
;
Humans
;
Hypocalcemia
;
Kidney Diseases*
;
Kidney*
;
Korea*
;
Pediatrics
;
Plasma Exchange*
;
Plasma*
;
Retrospective Studies
2.Therapeutic Plasma Exchange in Pediatric Kidney Disease: 23-year Experience at the Severance Children's Hospital in Korea.
Sun Mi HER ; Keum Hwa LEE ; Ji Hong KIM ; Jae Seung LEE ; Pyung Kil KIM ; Jae Il SHIN
Childhood Kidney Diseases 2017;21(2):81-88
PURPOSE: The American Society for Apheresis provides clinical guidelines for therapeutic apheresis in adults, but there are no guidelines for children. This study aimed to analyze the effect of therapeutic plasma exchange (TPE) in pediatric patients with various kidney diseases in Korea. METHODS: We retrospectively reviewed the data of 16 children (up to 18 years of age) who were admitted to Severance Children's Hospital with refractory kidney disease. All patients received TPE between 1994 and 2016. Clinical and laboratory characteristics such as age, weight, sex, change in blood urea nitrogen (BUN), and creatinine level before and after TPE, and complications after TPE were analyzed. RESULTS: The mean age and weight of the 16 patients at the time of TPE was 11.3±4.0 years and 34.6±17.5 kg, respectively. The BUN level was 35.4 mg/dL before TPE and significantly decreased to 21.5 mg/dL (P=0.025) at 1 week and 20.5 mg/dL (P=0.01) at 1 month after TPE. The creatinine level significantly decreased from 1.20 mg/dL before TPE to 0.90 mg/dL (P=0.02) at 1 week after TPE. Four complications (hypovolemia, anemia, hypocalcemia, and thrombocytopenia) were reported, but were not fatal. CONCLUSION: Our findings suggest that TPE is an effective therapeutic modality in children with refractory kidney disease and can be indicated for the treatment of various kidney diseases.
Adult
;
Anemia
;
Blood Component Removal
;
Blood Urea Nitrogen
;
Child
;
Creatinine
;
Humans
;
Hypocalcemia
;
Kidney Diseases*
;
Kidney*
;
Korea*
;
Pediatrics
;
Plasma Exchange*
;
Plasma*
;
Retrospective Studies
3.Noninfectious Complications of Peritoneal Dialysis in Korean Children: A 26-Year Single-Center Study.
Ji Eun KIM ; Se Jin PARK ; Ji Young OH ; Ji Hong KIM ; Jae Seung LEE ; Pyung Kil KIM ; Jae Il SHIN
Yonsei Medical Journal 2015;56(5):1359-1364
PURPOSE: The aim of this study was to investigate noninfectious complications of peritoneal dialysis (PD), including mechanical and metabolic complications, at a single center in Korea. MATERIALS AND METHODS: We analyzed data from 60 PD patients aged < or =18 years (40 boys and 20 girls) during the period between 1986 and 2012. The collected data included gender, age, causes of PD, incidence of noninfectious complications, and treatment for the complications. RESULTS: The mean duration of PD therapy was 28.7+/-42.1 months (range 1-240 months). The most common cause of end-stage renal disease was glomerular disease (43.3%). There were no statistically significant differences between patients with and without mechanical complications regarding gender, age at the start of PD, and total duration of PD. Outflow failure was the most common catheter-related complication (14.3%), followed by leakage (10.0%) and hernia (8.6%). Metabolic complications, such as hyperglycemia and hypokalemia, were observed in three of 16 patients. The frequency of noninfectious complications of PD in our study was comparable with those in previous pediatric studies. PD was switched to hemodialysis (HD) in only three patients. CONCLUSION: Our results indicate that noninfectious complications of PD are common, though they hardly lead to catheter removal or HD in pediatric patients on PD.
Adolescent
;
Asian Continental Ancestry Group
;
Catheterization/*adverse effects
;
Child
;
Child, Preschool
;
Device Removal
;
Female
;
Humans
;
Incidence
;
Kidney Failure, Chronic/*therapy
;
Male
;
*Outcome and Process Assessment (Health Care)
;
Peritoneal Dialysis/*adverse effects/instrumentation/*methods
;
Renal Dialysis/adverse effects
;
Republic of Korea
;
Treatment Outcome
4.Outcomes of Peritonitis in Children on Peritoneal Dialysis: A 25-Year Experience at Severance Hospital.
Kyong Ok LEE ; Se Jin PARK ; Ji Hong KIM ; Jae Seung LEE ; Pyung Kil KIM ; Jae Il SHIN
Yonsei Medical Journal 2013;54(4):983-989
PURPOSE: Relatively little is known on the microbiology, risk factors and outcomes of peritoneal dialysis (PD)-associated peritonitis in Korean children. We performed this study in order to evaluate the incidence, treatment and clinical outcomes of peritonitis in pediatric PD patients at Severance Hospital. MATERIALS AND METHODS: We analyzed data from 57 PD patients younger than 18 years during the period between June 1, 1986 and December 31, 2011. The collected data included gender, age at commencement of PD, age at peritonitis, incidence of peritonitis, underlying causes of end stage renal disease, microbiology of peritonitis episodes, antibiotics sensitivity, modality and outcomes of PD. RESULTS: We found 56 episodes of peritonitis in 23 of the 57 PD patients (0.43 episodes/patient-year). Gram-positive bacteria were the most commonly isolated organisms (40 episodes, 71.4%). Peritonitis developed in 17 patients during the first 6 months following initiation of PD (73.9%). Peritonitis episodes rarely resulted in relapse or the need for permanent hemodialysis and no patient deaths were directly attributable to peritonitis. Antibiotic regimens included cefazolin+tobramycin from the years of 1986 to 2000 and cefazolin+ceftazidime from the years of 2001 to 2011. While antibiotic therapy was successful in 48 episodes (85.7%), the treatment was ineffective in 8 episodes (14.3%). The rate of continuous ambulatory PD (CAPD) peritonitis was statistically higher than that of automated PD (APD) (p=0.025). CONCLUSION: Peritonitis was an important complication of PD therapy and we observed a higher incidence of PD peritonitis in patients with CAPD when compared to APD.
Adolescent
;
Anti-Bacterial Agents/therapeutic use
;
Cefazolin/therapeutic use
;
Ceftazidime/therapeutic use
;
Child
;
Child, Preschool
;
Female
;
Humans
;
Infant
;
Male
;
Peritoneal Dialysis/*adverse effects/methods
;
Peritoneal Dialysis, Continuous Ambulatory/*adverse effects
;
Peritonitis/drug therapy/epidemiology/*etiology/*microbiology
;
Tobramycin/therapeutic use
;
Treatment Outcome
5.Sedation and general anesthesia outside of the operating room.
Yoon Ji CHOI ; Mi Hyeon KIM ; Chang Sook SONG ; Sung Hoon KIM ; Jeong Yeon HONG ; Eun Ha SUK ; So Hyun KIL ; Heon Yong BAE ; Dong Hun KIM ; Pyung Hwan PARK
Anesthesia and Pain Medicine 2012;7(3):230-235
BACKGROUND: The aim of this study is to evaluate the status and adverse events of anesthesiologist-administered sedation and general anesthesia, outside of the operating room. METHODS: Patients undergoing sedation and general anesthesia, outside of the operating room, were retrospectively reviewed, during the study period from March to October of 2011. The patient's characteristics, primary diagnosis for the procedure, procedures performed outside of the operating room, adverse events associated with sedation and anesthesia, sedatives/anesthetic agents, and anesthetic time, were all assessed. RESULTS: A total of 429 patient's submitted data on 44 sedation/401 general anesthesia were encountered, during the study period. The range of age varied from 2 months to 83 yrs. Most common primary diagnosis for the procedure, during sedation or general anesthesia, was vascular or neurologic problem, respectively. The most frequently used sedatives or analgesics were propofol alone, during sedation (45%) and propofol with remifentanil, during general anesthesia (60%), respectively. Adverse events occurred in 32%, during sedation and 29%, during general anesthesia. Bradycardia occurred in 16% of sedation and hypotension occurred in 15% of general anesthesia. CONCLUSIONS: Our data suggest that the sedation/general anesthesia for procedures, outside of the operating room, have been performed in a complex situation, various location, and wide age groups. Adequate monitoring, sufficient anesthesia support, including skilled staff and emergency equipments, and appropriate drug for each procedure are needed for the patient's safety.
Analgesics
;
Anesthesia
;
Anesthesia, General
;
Bradycardia
;
Emergencies
;
Humans
;
Hypnotics and Sedatives
;
Hypotension
;
Operating Rooms
;
Piperidines
;
Propofol
;
Retrospective Studies
6.Dense Deposit Disease in Korean Children: A Multicenter Clinicopathologic Study.
Se Jin PARK ; Yong Jin KIM ; Tae Sun HA ; Beom Jin LIM ; Hyeon Joo JEONG ; Yong Hoon PARK ; Dae Yeol LEE ; Pyung Kil KIM ; Kyo Sun KIM ; Woo Yeong CHUNG ; Jae Il SHIN
Journal of Korean Medical Science 2012;27(10):1215-1221
The purpose of this study was to investigate the clinical, laboratory, and pathologic characteristics of dense deposit disease (DDD) in Korean children and to determine whether these characteristics differ between Korean and American children with DDD. In 2010, we sent a structured protocol about DDD to pediatric nephrologists throughout Korea. The data collected were compared with previously published data on 14 American children with DDD. Korean children had lower 24-hr urine protein excretion and higher serum albumin levels than American children. The light microscopic findings revealed that a higher percentage of Korean children had membranoproliferative glomerulonephritis patterns (Korean, 77.8%; American, 28.6%, P = 0.036), whereas a higher percentage of American children had crescents (Korean, 0%; American, 78.6%, P < 0.001). The findings from the electron microscopy revealed that Korean children were more likely to have segmental electron dense deposits in the lamina densa of the glomerular basement membrane (Korean, 100%; American, 28.6%, P = 0.002); mesangial deposit was more frequent in American children (Korean, 66.7%; American, 100%, P = 0.047). The histological findings revealed that Korean children with DDD were more likely to show membranoproliferative glomerulonephritis patterns than American children. The degree of proteinuria and hypoalbuminemia was milder in Korean children than American children.
Adolescent
;
Asian Continental Ancestry Group
;
Child
;
Child, Preschool
;
Creatinine/blood
;
Edema/etiology
;
Female
;
Glomerulonephritis, Membranoproliferative/*pathology
;
Hematuria/etiology
;
Humans
;
Infant
;
Infant, Newborn
;
Male
;
Microscopy, Electron
;
Proteinuria/etiology
;
Republic of Korea
;
Serum Albumin/analysis
;
United States
7.Effects of Cyclosporin A Therapy Combined with Steroids and Angiotensin Converting Enzyme Inhibitors on Childhood IgA Nephropathy.
Jae Il SHIN ; Beom Jin LIM ; Pyung Kil KIM ; Jae Seung LEE ; Hyeon Joo JEONG ; Ji Hong KIM
Journal of Korean Medical Science 2010;25(5):723-727
To evaluate the effects of cyclosporin A (CyA) on clinical outcome and pathologic changes in children with IgA nephropathy (IgAN), we retrospectively evaluated 14 children (mean age 8.9+/-2.9 yr; eight males, six females) who were treated with CyA and steroids. The starting dose of CyA was 5 mg/kg per day, and the drug level was maintained at 100-200 ng/mL. The mean CyA level was 183.8+/-48.3 ng/mL (range 120.7-276.0 ng/mL) and the mean duration of CyA therapy was 10.9+/-1.9 months (range 8-12 months). After CyA therapy the mean 24 hr urinary protein excretion declined from 107.1+/-35.1 mg/m2/hr to 7.4+/-2.4 mg/m2/hr (P<0.001) and serum albumin increased from 3.3+/-0.6 g/dL to 4.3+/-0.3 g/dL (P<0.001). At a follow-up biopsy the histological grade of IgAN was improved in seven (50%) of the 14 patients, remained the same in three (21%), and was aggravated in four (29%). Serum creatinine, creatinine clearance, and blood pressure did not differ before and after CyA therapy. Two patients (14%) showed CyA-induced nephrotoxicity at the second biopsy. Our findings indicate that CyA therapy may be effective in reducing proteinuria and regressing renal pathology in a subset of children with IgAN.
Angiotensin-Converting Enzyme Inhibitors/*administration & dosage
;
Child
;
Cyclosporine/*administration & dosage
;
Drug Combinations
;
Female
;
Glomerulonephritis, IGA/*diagnosis/*drug therapy
;
Humans
;
Immunosuppressive Agents/administration & dosage
;
Male
;
Steroids/*administration & dosage
;
Treatment Outcome
8.Causative Organisms of Community Acquired Urinary Tract Infection and Their Antibiotic Susceptibility at a Secondary hospital in Korea.
Yun Ju JO ; Eun Jeong LEE ; Kyong Min CHOI ; Young Min EUN ; Hwang Jae YOO ; Cheol Hong KIM ; Hyun Hee LEE ; Pyung Kil KIM
Korean Journal of Pediatric Infectious Diseases 2010;17(1):30-35
PURPOSE: We investigated the causative organism and its antibiotic susceptibility of community acquired urinary tract infection (UTI) in children at a secondary hospital to test the adequacy of the current guidelines. METHODS: Children diagnosed with UTI at the Department of Pediatrics, Kwandong University Myongji Hospital by pyuria and bacterial growth of greater than 1.0x10(5) CFU/mL on clean catch midstream urine from January 2005 to December 2008 were studied retrospectively. The epidemiologic data, causative organism, and the antibiotic susceptibility were analyzed. RESULTS: Sixty two children were diagnosed with sixty four cases of UTI's. Two bacteria were isolated in one case and thus data on 65 urine cultures were analyzed. The male:female ratio was 1.6:1 and 78.1% were less than 12 months of age. Escherichia coli was the predominant cause consisting of 53 cases (82.8%) of the cases. K. pneumoniae (5), Enterobacter (4), Enterococcus (1), beta-streptococcus (1), Diphtheroides (1) were isolated. The antibiotic resistance of E. coli were as follows; ampicillin 69.8%, cefotaxime 1.9%, gentamicin 15.1%, amikacin 0.0%, levofloxacin 1.9%, and trimethoprim/sulfamethoxazole 26.4%. Only one case of the E. coli was extended spectrum beta-lactamase (ESBL) positive. CONCLUSION: Compared to prior reports from other tertiary hospitals in Korea, E. coli was the predominant cause in childhood UTI and the rate of ESBL positivity was low. The antibiotic resistance was also different compared to prior reports. We conclude that a difference in the cause and antibiotic resistance of childhood UTI exists between centers and this should be taken into consideration when prescribing antibiotics for childhood UTIs.
Amikacin
;
Ampicillin
;
Anti-Bacterial Agents
;
Bacteria
;
beta-Lactamases
;
Cefotaxime
;
Child
;
Drug Resistance, Microbial
;
Enterobacter
;
Enterococcus
;
Escherichia coli
;
Gentamicins
;
Humans
;
Korea
;
Ofloxacin
;
Pediatrics
;
Pneumonia
;
Pyuria
;
Retrospective Studies
;
Tertiary Care Centers
;
Urinary Tract
;
Urinary Tract Infections
9.Development of IgA Nephropathy after Clinical Remission of Dense Deposit Disease.
Min Ju KIM ; Beom Jin LIM ; Jae Il SHIN ; Jae Seung LEE ; Yoon Hee LEE ; Kensuke JOH ; Pyung Kil KIM ; Hyeon Joo JEONG
Korean Journal of Nephrology 2010;29(1):125-130
Dense deposit disease (DDD) is a rare primary glomerulonephritis characterized by continuous band- like intramembranous dense deposits detectable on electron microscopy. We describe a case of DDD with sequential mesangial proliferative glomerulonephritis, membranoproliferative glomerulonephritis, minor glomerular alterations, and a second round of mesangial proliferative glomerulonephritis during a 13-year period. Electron dense deposits were typical of DDD in the first and second biopsies taken one year apart. However, deposits dissolved and the glomerular cellularity and basement membrane normalized with clinical remission, which was achieved by a course of immunosuppressive therapy lasting seven years. The fourth biopsy was performed due to recurrence of microscopic hematuria and showed predominant mesangial IgA deposits without glomerular capillary alteration, which was interpreted as development of IgA nephropathy after remission of DDD or coexistence with nearly healed DDD in this patient.
Basement Membrane
;
Biopsy
;
Capillaries
;
Dichlorodiphenyldichloroethane
;
Electrons
;
Glomerulonephritis
;
Glomerulonephritis, IGA
;
Glomerulonephritis, Membranoproliferative
;
Hematuria
;
Immunoglobulin A
;
Microscopy, Electron
;
Recurrence
10.Clinicopathologic Changes of IgA Nephropathy in Children During Long-term (average 10.8 yrs) Follow-up.
Chang Min MOON ; Pyung Kil KIM ; Beom Jin LIM ; Ji Sun SONG ; Hyeon Joo JEONG
Journal of the Korean Society of Pediatric Nephrology 2010;14(2):154-165
PURPOSE: We know little about the natural course of IgA nephropathy (IgAN) in association with histologic changes especially in children. We investigated clinicopathologic features with long-term follow-up biopsy to clarify the outcomes and prognostic indicators for childhood IgAN. METHODS: From our patients' medical records, we retrieved 20 patients with IgAN, to whom renal biopsies had been performed for the initial diagnosis and follow-up to find out any histologic changes. Initial and follow-up biopsies were classified by Haas classification. The changes of these parameters were compared with the evolution of clinical features. RESULTS: Patients were treated with angiotensin-converting enzyme inhibitors in combination with angiotensin receptor blockers (in subclass II or above) and short-term cyclosporine A(in patients showing nephrotic syndrome). Histologic improvement in 7 cases and deterioration in 3 cases were observed. At the time of last biopsy, 10 cases (50%) showed clinical remission and the others showed improved clinical features. These clinical outcomes did not correlate with initial Haas classifications. Hypertension at onset observed in 5 cases (25%) revealed significant correlation with clinical outcome (P=0.01) and last Haas classification (P=0.007). None of the cases showed progression to CRF or ESRD. CONCLUSION: During a mean follow-up of 10.8+/-3.4 years, childhood IgAN showed good clinicopathologic outcome. Hypertension at onset was only a strong predictor of clinicopathologic outcomes, but initial Haas classification cannot predict outcomes in children. Histologic change of IgAN in long term follow-up period cannot be completely predicted by clinical data and vice versa. Therefore, a renal biopsy should be considered as a part of follow-up plan.
Angiotensin Receptor Antagonists
;
Angiotensin-Converting Enzyme Inhibitors
;
Biopsy
;
Child
;
Cyclosporine
;
Follow-Up Studies
;
Glomerulonephritis, IGA
;
Humans
;
Hypertension
;
Immunoglobulin A
;
Medical Records
;
Prognosis

Result Analysis
Print
Save
E-mail